It is a pharma private limited company based in Ahmedabad, Gujarat, India, established in 2013.
2013 | Ahmedabad, Gujarat, India | ActiveRishmaan Lifesciences Private Limited, a active private limited company, was established on 21 March 2013 in Ahmedabad, Gujarat, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24239GJ2013PTC074116. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Vimalkumar Bhanwarlal Jain (Managing Director), Rahul Mithalal Shah (Whole-Time Director), Dimple Jain (Whole-Time Director). Past directors included Babulal Valchand Shah, Vimalkumar Bhanwarlal Jain, Rahul Mithalal Shah. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 106, Shanay-2, Nr Hemkoot Building Nr.Gandhigram Rly Station, Ashram Road,, Ahmedabad, Gujarat, 380006.
U24239GJ2013PTC074116
074116
21 March 2013
₹0.10 M
₹0.10 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Rishmaan Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vimalkumar Bhanwarlal Jain | Managing Director | 21 Mar 2013 | Current |
| Rahul Mithalal Shah | Whole-Time Director | 21 Mar 2013 | Current |
| Dimple Jain | Whole-Time Director | 21 Mar 2013 | Current |
| Sumit Champalal Shah | Whole-Time Director | 21 Mar 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Whole-Time Director | 16 Jul 2015 | Past |
| Pramod Abcsdd | Director | 24 Apr 2013 | Past |
| Pramod Abcsdd | Director | 24 Apr 2013 | Past |
| Pramod Abcsdd | Director | 24 Apr 2013 | Past |
| Pramod Abcsdd | Director | 24 Apr 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rishmaan Lifesciences Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 51.15% increase in profit. The company's net worth dipped by a decrease of 8.73%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Rishmaan Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Rishmaan Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Rishmaan Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rishmaan Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Rishmaan Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Rishmaan Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was recorded as a recent event.
Progress on Vimalkumar Bhanwarlal Jain was appointed as a Managing Director was appointed as a Managing Director on 21 Mar 2013 & has been associated with this company since 12 years 9 months . was documented.
Rahul Mithalal Shah was appointed as a Whole-time director was appointed as a Whole-time director on 21 Mar 2013 & has been associated with this company since 12 years 9 months . was recorded as a recent event.
Progress on Dimple Jain was appointed as a Whole-time director was appointed as a Whole-time director on 21 Mar 2013 & has been associated with this company since 12 years 9 months . was documented.
Sumit Champalal Shah was appointed as a Whole-time director was appointed as a Whole-time director on 21 Mar 2013 & has been associated with this company since 12 years 9 months . was recorded as a recent event.
The CIN of Rishmaan Lifesciences Private Limited is U24239GJ2013PTC074116.
Rishmaan Lifesciences Private Limited is headquartered at 106, Shanay-2, Nr Hemkoot Building Nr.Gandhigram Rly Station, Ashram Road,, Ahmedabad, Gujarat, 380006.
Rishmaan Lifesciences Private Limited was incorporated on 21 March 2013.
The current directors of Rishmaan Lifesciences Private Limited are
The primary industry of Rishmaan Lifesciences Private Limited is Trade.
Rishmaan Lifesciences Private Limited is unlisted.
The authorized capital of Rishmaan Lifesciences Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Rishmaan Lifesciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX